Wolthers K C, Otto S A, Wisman G B, Fleury S, Reiss P, ten Kate R W, van der Zee A G, Miedema F
Department of Clinical Viro-Immunology, CLB, Sanquin Blood Supply Foundation, Amsterdam.
Blood. 1999 Feb 1;93(3):1011-9.
In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity could explain differential telomere loss of CD4(+) and CD8(+) T cells in HIV-1 infection. Telomerase activity was higher in CD8(+) than in CD4(+) T cells from HIV-infected patients, but still in the same range as in healthy controls, and upregulation after stimulation was comparable to normal. Telomerase activity in lymph node CD4(+) and CD8(+) T cells from HIV-infected patients was in the same range as that in CD4(+) and CD8(+) T cells from peripheral blood (PB) and was normal in unseparated bone marrow cells. Thus, our study did not provide evidence for compartmentalized elongation of telomeres in HIV infection. In patients treated with reverse transcriptase inhibitors, telomerase activity was inhibited, but this did not lead to accelerated loss of telomere length in vivo. Thus, differential telomere loss in CD4(+) and CD8(+) T cells in HIV-1 infection cannot be explained by telomerase activity.
在人类免疫缺陷病毒(HIV)-1感染中,端粒长度的缩短主要出现在CD8(+)T细胞中,而不是CD4(+)T细胞中。端粒酶是一种核糖核蛋白酶,可在染色体末端合成端粒序列,能够补偿端粒的损耗。在此,我们研究了端粒酶活性是否可以解释HIV-1感染中CD4(+)和CD8(+)T细胞端粒损耗的差异。HIV感染患者的CD8(+)T细胞中的端粒酶活性高于CD4(+)T细胞,但仍与健康对照处于同一范围,刺激后的上调与正常情况相当。HIV感染患者淋巴结中CD4(+)和CD8(+)T细胞的端粒酶活性与外周血(PB)中CD4(+)和CD8(+)T细胞的端粒酶活性处于同一范围,并且在未分离的骨髓细胞中是正常的。因此,我们的研究没有为HIV感染中端粒的分区延长提供证据。在用逆转录酶抑制剂治疗的患者中,端粒酶活性受到抑制,但这并未导致体内端粒长度加速损耗。因此,HIV-1感染中CD4(+)和CD8(+)T细胞端粒损耗的差异不能用端粒酶活性来解释。